Potenzial nach massiven Kurssturz Balchem (905650)

Beiträge: 33
Zugriffe: 13.324 / Heute: 5
Balchem 129,76 $ -1,46% Perf. seit Threadbeginn:   +316,57%
 
Potenzial nach massiven Kurssturz Balchem (905650) raketentrader
raketentrader:

Potenzial nach massiven Kurssturz Balchem (905650)

2
02.04.12 18:40
#1

A Downtrend for Balchem (NASDAQ:BCPC) on January 23rd, 2012 at $38.73. In approximately 2 months, Balchem has returned 22.67% as of today's recent price of $29.95.

Balchem share prices have moved between a 52-week high of $47.23 and a 52-week low of $26.56 and are now trading 13% above that low price at $29.95 per share. Over the last five market days, the 200-day moving average (MA) has gone down 0.4% while the 50-day MA has declined 2.1%.

Balchem Corporation develops, manufactures, and markets specialty performance ingredients for the food, feed, and medical sterilization industries. The Company micro-encapsulates performance ingredients, and also repackages and markets specialty gases. Balchem sells its products through its own sales force, independent distributors, and sales agents.


Potenzial nach massiven Kurssturz Balchem (905650) raketentrader
raketentrader:

Ergebnisse des 4. Quartals 2011

 
07.04.12 14:09
#2

http://www.balchem.com/news/balchem-corporation-announces-fourth-quarter-2011-results

So schlecht schauen die Zahlen auch wieder nicht aus

Potenzial nach massiven Kurssturz Balchem (905650) raketentrader
raketentrader:

zwar schon bisschen älter

 
10.04.12 10:17
#3

aber trotzdem sehr interessant

Rosenheim (aktiencheck.de AG) - Die Experten von "boerse.de-Aktienbrief"  nutzen den Aufwärtstrendwechsel bei der Aktie von Balchem  (<US0576652004>/ <US0576652004>) zum Einstieg. Laut aktuellem Forbes-Ranking sei dieses US-Spezialchemieunternehmen die  Nummer 29 unter "Americas best Small Companies". Schwerpunkte seien  Nahrungsergänzungsmittel, Zusatzstoffe für die Pharmaindustrie,  Tierfutter sowie medizintechnische Spezialerzeugnisse. Damit seien im  dritten Quartal abermals Rekordergebnisse verbucht worden, wobei die  Umsätze um 16% auf 74 Mio. USD gestiegen seien, während der Gewinn (11  Mio. USD) sogar um 27% nach oben geschnellt sei. Die Aktie glänze mit  einem mustergültigen Kursverlauf von links unten nach rechts oben, der  sich in hervorragenden Performance-Kennzahlen niederschlage. Seit 2001  sei Balchem mit einer hohen Gewinn-Konstanz im Schnitt 24% p.a.  aufgesattelt, wobei die Verlust-Ratio von 2,09 unterdurchschnittlich  ausfalle. Nach dem August-Rücksetzer gelang jetzt der erneute Aufwärtstrendwechsel  bei der Balchem-Aktie, den die Experten von "boerse.de-Aktienbrief" zum  zweiten Einstieg nutzen. Damit würden sie sich 12% Crash-Rabatt  gegenüber dem Juli-All-Time-High sichern, und bis 2016 errechne sich  eine Gewinn-Perspektive von 170%. (Ausgabe 253 vom 16.11.2011)  (18.11.2011/ac/a/a)

Potenzial nach massiven Kurssturz Balchem (905650) raketentrader
raketentrader:

balchem

 
05.05.12 09:44
#4

http://www.fool.com/investing/general/2012/05/03/...timates-on-e.aspx

Balchem ( Nasdaq: BCPC     ) reported earnings yesterday. Here are the numbers you need to

... (automatisch gekürzt) ...

http://www.fool.com/investing/general/2012/05/03/...timates-on-e.aspx
Moderation
Zeitpunkt: 07.05.12 10:56
Aktion: Kürzung des Beitrages
Kommentar: Urheberrechtsverletzung, ggf. Link-Einfügen nutzen - Bitte nur kurz zitieren.
Original-Link: http://www.fool.com/investing/general/...stimates-on-e.aspx

Link: Forumregeln  

Potenzial nach massiven Kurssturz Balchem (905650) raketentrader
raketentrader:

Ein heller Stern

 
13.08.12 17:09
#5

The 10-second takeaway
For the quarter ended June 30 (Q2), Balchem beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew and GAAP earnings per share grew.

Gross margins dropped, operating margins were steady, net margins dropped.

Revenue details
Balchem reported revenue of $79.0  million. The three analysts polled by S&P Capital IQ predicted  revenue of $76.0 million on the same basis. GAAP reported sales were  5.8% higher than the prior-year quarter's $74.7 million.

Potenzial nach massiven Kurssturz Balchem (905650) Safer4
Safer4:

3. Quartal

 
03.11.12 09:13
#6
Balchem Corporation Announces Third Quarter 2012 Results

www.balchem.com/news/...n-announces-third-quarter-2012-results
Potenzial nach massiven Kurssturz Balchem (905650) brunneta
brunneta:

Balchem - mit 188% Kurspotenzia?l!

 
09.02.14 07:50
#7
www.boerse.de/top-news/...em-188Prozent-Kurspotenzial-/7456255
Keine Kauf-Verkaufsempfehlung.   "Das Glück des einen ist das Unglück des anderen"
Potenzial nach massiven Kurssturz Balchem (905650) Solventzo
Solventzo:

Balchem - charttechnisch...

2
28.02.14 10:25
#8
schaut's auch gut aus

Potenzial nach massiven Kurssturz Balchem (905650) 17502069
Potenzial nach massiven Kurssturz Balchem (905650) Safer4
Safer4:

1. Quartal

 
05.05.14 16:12
#9
www.balchem.com/news/...n-Announces-First-Quarter-2014-Results
Der ARIVA.DE Newsletter
Bleiben Sie informiert mit dem
wöchentlichen Marktüberblick
von ARIVA.DE!
E-Mail-Adresse
Ich möchte Benachrichtigungen von ARIVA.DE erhalten.
Ja, ich habe die Datenschutzhinweise gelesen und akzeptiert (Pflichtfeld).
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Dividende

 
04.02.15 19:56
#10
NEW HAMPTON, N.Y., Dec. 19, 2014 (GLOBE NEWSWIRE) -- Balchem Corporation (BCPC) today announced that its Board of Directors has declared a dividend on its shares of common stock equal to $0.30 per share, payable on January 27, 2015 to holders of record on December 29, 2014. This dividend reflects a 15% increase over the prior year cash dividend.Dino A. Rossi, Balchem's Chairman, President and CEO, stated, "As discussed in previous years regarding our dividend philosophy, we have positioned to maximize future returns for our shareholders, using capital for various growth objectives, as well as sharing near-term financial gains with our shareholders. This positioning helped us to execute the acquisition of SensoryEffects this year, and while challenging from an integration standpoint, we have continued to deliver quality financial results, and hence, this dividend reiterates our commitment to our shareholders."

About Balchem

Balchem Corporation consists of three business segments: ARC Specialty Products; SensoryEffects (formerly Food, Pharma & Nutrition); and Animal Nutrition & Health. Through ARC Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries. The SensoryEffects segment provides customized food and beverage ingredient systems and proprietary microencapsulation solutions to a variety of applications in the human food, pharmaceutical and nutrition marketplaces. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets and certain derivative products into industrial applications.
Forward-Looking Statements

This release contains forward-looking statements, which reflect Balchem's expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward looking statements will prove correct and various factors could cause results to differ materially from Balchem's expectations, including risks and factors identified in Balchem's annual report on Form 10-K for the year ended December 31, 2013. Forward-looking statements are qualified in their entirety by the above cautionary statement. Balchem assumes no duty to update its outlook or other forward-looking statements as of any future date.


finance.yahoo.com/news/...on-announces-dividend-200000807.html
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

First quarter 2015

 
29.05.15 19:52
#11
balchem.com/investor-relations

balchem.com/news/...lchem-announces-first-quarter-2015-results

de.4-traders.com/BALCHEM-CORPORATION-39847/fundamentals/
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Mai 2015 Presentation

 
19.06.15 23:29
#12
balchem.com/sites/default/files/...esentation%20May%202015.pdf
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Meinung zum heutigen Kursrückgang

 
24.06.15 21:21
#13
seekingalpha.com/article/...ity-in-this-world-class-compounder
Potenzial nach massiven Kurssturz Balchem (905650) Rentnerzock
Rentnerzock:

Balchem

 
13.10.15 09:59
#14
hat in diesem Jahr fast nur die Seitwärtsbewegung ausgeführt und hat in den
letzten Tagen vermutlich den Weg nach Norden gewählt.
Die Aktie habe ich am 27.5.2014 für 41,34€ gekauft, heute steht sie 57,6€.
Wie ich gelesen habe, gilt sie als unterbewertet. Der Kurs scheint in Bewegung zu
kommen, und zwar in die richtige Richtung nach Norden und hat ein Hoch gebildet,
zudem kommt im Dez. die Div.-Zahlung. Die Höhe der bisherigen Zahlungen scheint
stetig nach oben zu gehen und dies kann ich als stabil bezeichnen. Ich glaube, eine
gute Kaufgelegenheit mit Signal.
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Schöne News

 
02.02.16 17:09
#15
finance.yahoo.com/news/...albion-international-180810470.html

Balchem Corporation Acquires Albion International, Inc.

NEW HAMPTON, N.Y., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Balchem Corporation (BCPC) today announced that it acquired Albion International, Inc., a privately held manufacturer of mineral amino acid chelates, specialized mineral salts and mineral complexes, headquartered in Clearfield, Utah for a purchase price of $111.5 million in cash. Albion’s 2015 revenues were approximately $53.5 million. The acquisition purchase price reflects a multiple of approximately 10.7 times 2015 EBITDA, excluding any synergies. The transaction consideration is subject to certain adjustments as provided in the definitive agreement. The purchase price will be financed through the Company’s existing revolving credit facility and cash on hand.  The transaction is expected to be immediately accretive to Balchem’s earnings per share.




Albion has been a world leader and innovator in the manufacture of superior organic mineral compounds for sixty years.  With over 100 patents, Albion leverages scientific expertise in the areas of both human and plant nutrition. Albion’s products are renowned in the supplement industry for technologically advanced, unparalleled bioavailability.

With this acquisition, Balchem continues to expand its science based human health and wellness solutions.  Already the global leader in the essential nutrient, choline, Balchem will immediately expand the combined company's product offerings in the nutritional ingredient market by adding Albion’s premier branded innovative chelated minerals to its portfolio.  The combined company will also benefit from a broader geographic footprint and an even stronger position as a technological leader in spray-drying and ingredient delivery solutions.

“We are very excited to add Albion’s deep scientific expertise, broad patent portfolio, and premium branded products to our company.  This acquisition creates a broader nutritional platform for Balchem that will help our customers improve their nutritional and wellness solutions,” said Ted Harris, President and CEO of Balchem.

About Balchem
Balchem Corporation consists of four business segments:  SensoryEffects; Animal Nutrition and Health; Specialty Products; and Industrial Products.  The SensoryEffects segment provides customized food and beverage ingredient systems and proprietary microencapsulation solutions to a variety of applications in the human food, pharmaceutical and nutrition marketplaces. The Animal Nutrition and Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and the Industrial Products segment, provides certain derivative products into industrial applications, predominately as a component for hydraulic fracturing of shale natural gas wells.

Forward-Looking Statements
Any statements in this press release about future expectations, plans and prospects for Balchem or SensoryEffects and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will,” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements reflect Balchem’s expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward-looking statements will prove correct and various factors could cause results to differ materially from Balchem’s expectations and risks and factors identified in Balchem’s annual report on Form 10-K for the year ended December 31, 2014. Forward-looking statements are qualified in their entirety by the above cautionary statement. Balchem assumes no duty to update its outlook or other forward-looking statements as of any future date, except as required by law.


Contact:


Balchem Contact:
Suzanne Hart, Investor Relations
Telephone:  845-326-5600
E-mail: bcpc-ir@balchem.com
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q4 15 Earnings call

 
03.03.16 16:57
#16
seekingalpha.com/article/...5-results-earnings-call-transcript


Balchem Corporation Reports Record Adjusted Earnings Per Share of $2.51 for Full Year 2015; Fourth Quarter Adjusted Earnings Per Share of $0.66



seekingalpha.com/pr/...gs-per-share-2_51-full-year-2015-fourth
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

First Quarter 2016

 
10.05.16 16:42
#17
finance.yahoo.com/news/...ports-adjusted-ebitda-130000120.html
.
NEW HAMPTON, N.Y., May 10, 2016 (GLOBE NEWSWIRE) -- Balchem Corporation (BCPC) today reported for the first quarter 2016 adjusted EBITDA(a) of $35.5 million, compared to $36.1 million in the prior year quarter and $33.7 million sequentially from the fourth quarter 2015. Adjusted EBITDA margin expanded to 26.2% from 24.9% and 25.4% in the prior year quarter and fourth quarter 2015, respectively, and this was a significant contributor to these results in a challenging oil & gas and dairy market environment.


First Quarter 2016 Financial Highlights:
•Net sales of $135.1 million, a decrease of 6.7% compared to the first quarter of 2015, with the most significant driver of this decline being a $13.6 million reduction in sales in Industrial Products.
•Without the impact of Albion, record first quarter earnings for our Human Nutrition & Health (formerly SensoryEffects)(b) segment and record first quarter sales and record first quarter earnings for our Specialty Products(c) segment.
•Adjusted EBITDA margin improved to 26.2% versus 24.9% in the first quarter 2015 and 25.4% sequentially from the fourth quarter 2015 principally due to improved product mix and lower raw material costs.
•Adjusted earnings per share(a) of $0.58 decreased $0.04 or 6.5% from the prior year.
•Record first quarter cash flows from operations generated of $29.3 million.
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q3 16

 
07.11.16 19:42
#18
www.zacks.com/research/get_news.php?id=udt4ejivwb
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Wachstum intakt Zahlen

 
28.02.17 20:17
#19
finance.yahoo.com/news/blachem-posts-4q-profit-132332147.html
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

SA Artikel aus 08.16

 
28.02.17 20:53
#20
seekingalpha.com/article/...chem-intact-long-term-growth-story
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q1 17

 
09.05.17 20:25
#21
www.4-traders.com/...5-Million-and-First-Quarter-Adj-24352771/
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q2 17

 
05.08.17 18:01
#22
www.4-traders.com/...e-beating-Walls-Streets-expecta-24895966/
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q3 17

 
07.11.17 16:32
#23
www.4-traders.com/...h-Record-Third-Quarter-Net-Earn-25454884/
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q4 17

 
27.02.18 20:14
#24
www.4-traders.com/...ith-Record-Net-Earnings-of-42-0-26067026/
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q1 18 wieder gut

 
04.05.18 18:25
#25
www.4-traders.com/...illion-Record-First-Quarter-Net-26514877/
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q3

 
06.11.18 20:40
#26
www.marketscreener.com/...chem-3Q-Earnings-Snapshot-27555451/

www.marketscreener.com/...d-Quarter-Net-Earnings-of-27554610/
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q4

 
28.02.19 16:37
#27
www.marketscreener.com/...es-of-163-5-million-Fourt-28085287/

02/28/2019 | 07:03am EST
Fourth quarter net sales of $163.5 million, growth of 2.7%, compared to prior year. Full year 2018 sales of $643.7 million, an increase of 8.2% from the prior year, with year over year sales growth in all four of our segments.
Fourth quarter GAAP EPS of $0.63, and adjusted EPS(a) of $0.77, an increase in adjusted EPS(a) of 13.2% compared to prior year. Full year GAAP EPS of $2.42, and adjusted EPS(a) of $3.01, an increase in adjusted EPS(a) of 19.0% from the prior year.
Fourth quarter cash flow from operations of $39.5 million and free cash flow(a) of $33.6 million, up 57.6% compared to prior year. Full year cash flow from operations of $118.7 million and free cash flow(a) of $99.5 million, up 19.8% compared to prior year.
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q1

 
03.05.19 15:15
#28
www.globenewswire.com/news-release/2019/05/...EPS-of-0-73.html
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q3

 
05.11.19 19:32
#29
www.marketscreener.com/...chem-3Q-Earnings-Snapshot-29517948/

Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q4

 
25.02.20 19:21
#30
www.balchem.com/wp-content/uploads/2020/...elease-Q4-2019.pdf

www.balchem.com/investor-relations/

Current Financials: Updated: February 21, 2020

• Fourth quarter net sales of $166.5 million, an increase of $3.0 million, or 1.8%, compared to the prior year quarter.
• Year over year quarterly sales growth in three of the four segments, with all-time record sales in Human Nutrition and Health and Animal Nutrition and Health, and record fourth quarter sales in Specialty Products.
• Fourth quarter GAAP net earnings of $20.4 million were slightly higher than the prior year. These net earnings resulted in GAAP earnings per share of $0.63.
• Quarterly adjusted net earnings of $28.4 million increased $3.3 million or 12.9% from the prior year, resulting in adjusted earnings per share of $0.88.
• Fourth quarter adjusted EBITDA was $40.0 million, an increase of $0.4 million, or 1.0%, from the prior year.
• Quarterly cash flows from operations were $33.0 million for the fourth quarter 2019 with quarterly free cash flow of $26.3 million.



Full Year 2019 Financial Highlights
• Full year net sales of $643.7 million were slightly higher than the prior year.
• Year over year sales growth in three of the four segments, with all-time record sales in Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products, offset by reduced sales in Industrial Products.
• Full year GAAP net earnings were $79.7 million, an increase of $1.1 million, or 1.4% from the prior year. These net earnings resulted in GAAP earnings per share of $2.45.
• Full year adjusted net earnings of $103.7 million increased $5.9 million or 6.1% from the prior year, resulting in adjusted earnings per share of $3.19.
• Full year adjusted EBITDA was $160.0 million, an increase of $0.7 million, or 0.5%, from the prior year.
• Full year cash flows from operations were $124.5 million for 2019 with full year free cash flow of $96.1 million.
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q2

 
14.08.20 14:42
#31
www.marketscreener.com/...chem-2Q-Earnings-Snapshot-31030373/

www.marketscreener.com/...Results-of-Operations-All-31032722/
Potenzial nach massiven Kurssturz Balchem (905650) Tamakoschy
Tamakoschy:

Q4

 
22.02.21 16:52
#32
www.marketscreener.com/quote/stock/...ings-Snapshot-32481161/

seekingalpha.com/article/...&utm_source=twitter_automated
Gelöschter Beitrag. Einblenden »
#33



Hot-Stocks-Forum - Gesamtforum - Antwort einfügen - zum ersten Beitrag springen

Neueste Beiträge aus dem Balchem Forum

  
Wertung Antworten Thema Verfasser letzter Verfasser letzter Beitrag
2 32 Potenzial nach massiven Kurssturz Balchem (905650) raketentrader Christinmlwha 25.04.21 00:57

--button_text--